Skip to main content

To learn more about Triangle CERSI, join our mailing list for future communications.

To learn more about Triangle CERSI, join our mailing list for future communications.

To learn more about Triangle CERSI, join our mailing list for future communications.

To learn more about Triangle CERSI, join our mailing list for future communications.

To learn more about Triangle CERSI, join our mailing list for future communications.

To learn more about Triangle CERSI, join our mailing list for future communications.

Triangle 003: Enhancing the role of pharmacies in reducing opioid misuse and abuse in racial and ethnic minority and rural communities

Research

Enhancing the role of pharmacies in reducing opioid misuse and abuse in racial and ethnic minority and rural communities

CERSI P.I.s and Collaborators
Tamera Hughes, Pharm.D, Ph.D (UNC-CH); Stefanie Ferreri, Pharm.D. (UNC-CH); Delesha Carpenter, Ph.D., M.S.P.H. (UNC-Asheville); Lori Armistead, Pharm.D. (UNC-CH); Tamara Baker, PhD (UNC-CH); Abby Gamble (UNC-Asheville)

FDA SMEs and Collaborators
Olga Rass, PhD; Caroline Huang, PhD; Veronica Uzoebo, EdD, MBA, MS, MA; Blair Coleman, PhD, MPH; Lukas Glos, MA; Henry Appiah, PharmD; Sheheryar Muhammad, PharmD; Amy Seitz, PhD, MPH; Candice Collins, DrPH; Mitra Ahadpour, MD, DABAM; Nancy Chang, MD; Sandrine Ly, PharmD; Paula Rausch, PhD, RN; Brian Gac, PharmD; Hillary Dolinsky, MBA, MSW; Christine Lee, PharmD, PhD; Julie Hsieh, PhD, MPH

The misuse of opioid medications harms many people, impacting both patients and communities. Some populations and geographic areas have less access to support services for opioid misuse, resulting in greater health harms. 

For example, the number of opioid overdose deaths has been increasing in the United States, especially for those living in rural areas and among racial and ethnic minority communities (e.g., non-Hispanic Black or African American and non-Hispanic American Indian or Alaska Native people). 

This project identifies new ways to help reduce harms from opioid misuse by supporting treatment for opioid use disorder and increasing access to medications that reverse opioid overdoses for all people, regardless of where they live or who they are.

Project Description and Goals

The goal of this project is to understand how community pharmacies work collaboratively with patients to reduce the harm that opioid misuse can cause. We are also seeking to understand what challenges community pharmacies face when trying to decrease harm from opioids by supporting safe use of opioid medications and access to medications for opioid use disorder treatment and opioid overdose reversal. We are focusing our information gathering efforts on community pharmacies that serve racial and ethnic minorities in rural areas by sending out surveys and interviewing pharmacists, pharmacy technicians, patients, and other community members to achieve these goals. Ultimately, we want to explore effective ways to reduce the harm from opioid misuse among underserved communities.

How does this project fit into the FDA's Regulatory Science Framework?

This project aims to invigorate public health preparedness and response of the FDA toward addressing substance use and misuse in patients & consumers.

PI in the news: Dr. Delesha Carpenter

Learn how Triangle CERSI's Dr. Delesha Carpenter is making an impact through regulatory science.